Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to UY26394ApriorityCriticalpatent/UY26394A1/en
Publication of UY26394A1publicationCriticalpatent/UY26394A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención se refiere a compuestos de fórmula I, y a sus sales farmacéuticamente aceptables. Los compuestos de fórmula I exhiben actividad como inhibidores de la recaptación de serotonina, norepinefrina y dopamina y pueden utilizarse en el tratamiento de trastornos del sistema nervioso central y de otros trastornos.The present invention relates to compounds of formula I, and their pharmaceutically acceptable salts. The compounds of formula I exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibitors and can be used in the treatment of disorders of the central nervous system and other disorders.
UY26394A2000-10-122000-10-12
NEW BIARILETER DERIVATIVES USEFUL AS MONOAMINE RECOVERY INHIBITORS
UY26394A1
(en)